Authors:
STROHMAIER K
SNYDER E
DUBINER H
ADAMSONS I
Citation: K. Strohmaier et al., THE EFFICACY AND SAFETY OF THE DORZOLAMIDE-TIMOLOL COMBINATION VERSUSTHE CONCOMITANT ADMINISTRATION OF ITS COMPONENTS, Ophthalmology (Rochester, Minn.), 105(10), 1998, pp. 1936-1944
Authors:
ENG K
STROHMAIER K
PALMER R
STONER B
WASHBURN S
Citation: K. Eng et al., COMPARISON OF EXTERNAL AND INTERNAL PLANAR RADIO-FREQUENCY ANTENNAE FOR INDUCTIVELY-COUPLED PLASMA, Review of scientific instruments, 68(6), 1997, pp. 2381-2383
Authors:
STRAHLMAN ER
VOGEL R
TIPPING R
CLINESCHMIDT CM
LEWIS R
KEATES E
QUIGLEY H
ZIMMERMAN T
ABELSON MB
ALLEN RC
BROWN RH
CACIOPPO LR
CYRLIN MN
GIESER DK
GREENIDGE KC
GROSS RL
KARP DW
KOBY MM
KASS M
LAIBOVITZ R
MCMAHON CD
OSTROV CS
WALTERS T
RITCH R
SAMPLES JR
SCHUMAN SJ
SERLE J
VELATHOMAS MA
BOYLE J
LIPPA E
REINES S
STRAHLMAN E
STROHMAIER K
Citation: Er. Strahlman et al., THE USE OF DORZOLAMIDE AND PILOCARPINE AS ADJUNCTIVE THERAPY TO TIMOLOL IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE, Ophthalmology, 103(8), 1996, pp. 1283-1293
Authors:
LAIBOVITZ R
BOYLE J
SNYDER E
STROHMAIER K
ADAMSONS I
Citation: R. Laibovitz et al., DORZOLAMIDE VERSUS PILOCARPINE AS ADJUNCTIVE THERAPIES TO TIMOLOL - ACOMPARISON OF PATIENT PREFERENCE AND IMPACT ON DAILY-LIFE, Clinical therapeutics, 18(5), 1996, pp. 821-832
Authors:
BOYLE J
REINES S
STROHMAIER K
SNYDER E
ADAMSONS I
Citation: J. Boyle et al., A CLINICAL-TRIAL COMPARING PATIENT PREFERENCE AND IMPACT ON DAILY-LIFE ON TRUSOPT AND PILOCARPINE, Investigative ophthalmology & visual science, 37(3), 1996, pp. 164-164
Citation: K. Strohmaier et al., LONG-TERM SAFETY AND EFFICACY OF COSOPT - A FIXED COMBINATION OF DORZOLAMIDE AND TIMOLOL, Investigative ophthalmology & visual science, 37(3), 1996, pp. 5069-5069
Citation: K. Strohmaier et Oc. Straub, EXPECTATIONS FROM THE CESSATION OF VACCIN ATION AGAINST FOOT-AND-MOUTH-DISEASE IN EUROPEAN MEMBER STATES .4. THE NON-VACCINATION POLICY OF THE EUROPEAN-UNION, Tierarztliche Umschau, 50(4), 1995, pp. 255
Citation: K. Strohmaier et Oc. Straub, EXPECTATIONS FROM THE CESSATION OF VACCIN ATION AGAINST FOOT-AND-MOUTH-DISEASE IN EUROPEAN MEMBER STATES .2. CONCLUSIONS FROM THE COUNTRYWIDE VACCINATION PROGRAM IN GERMANY, Tierarztliche Umschau, 50(2), 1995, pp. 93
Citation: K. Strohmaier et Oc. Straub, FOOT-AND-MOUTH-DISEASE - EXPECTATIONS FRO M THE CESSATION OF VACCINATION .1. A RETROSPECTIVE REVIEW, Tierarztliche Umschau, 50(1), 1995, pp. 3-8
Authors:
STRAHLMAN ER
LIPPA EA
TIPPING R
SMITH B
STROHMAIER K
Citation: Er. Strahlman et al., A CONTROLLED CLINICAL-TRIAL OF 2.0-PERCENT DORZOLAMIDE (MK-507) COMPARED TO TIMOLOL AND BETAXOLOL, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2177-2177